All Party Branches under the Group Held Democratic Life Meeting
Release time:
2020-07-22
group held democratic life meetings
after the working ideas of the Party committee of the group in 2019 were determined, and in combination with the relevant spirit of the Party Central Committee and the higher-level Party committee, the party branches under the group held democratic life meetings successively to carry out criticism and self-criticism.
3# December 26 , Jinhua pharmaceutical company's operating branch held a democratic life meeting. At the meeting, Tong Jingchun, secretary of the management branch, took the lead in making criticism and self-criticism, and asked all party members of the management branch to work on the ground, to work steadily, and not to float on the surface. Other party members also expressed their views, believing that it is necessary to combine study with their own work, give full play to the role of party members, bear hardships first, take the lead in abiding by rules and regulations, set high standards and strict requirements in work, overcome difficulties, and strive to achieve goals.
August 1 , the Party branch of Jianfeng International Trading Company held a democratic life meeting. Party branch secretary He Keqin and all Party members studied the "Regulations on Disciplinary Actions of the Communist Party of China" and "Regulations on the Work of the Communist Party of China Branch (Trial)" and other documents, and took the lead in carrying out criticism and self-criticism. All party members also criticized and self-criticized from their own study, work, and thoughts, and conducted mutual evaluations and proposed improvement measures. Qin Xuping, member of the Party committee and director of the Party and Mass Work Department of the group company, attended the democratic life meeting of the Party branch of international trade. He stressed that party members should firmly establish the "Four Consciousness", strengthen the "four self-confidence", resolutely achieve the "two maintenance", carry forward the socialist core values, learn the "Jinhua spirit" -- faithfulness and beauty, hard work, and build strength together, Encourage Party members to work in the forefront. He hoped that all party members would follow the "ten non-standards," be cautious in their words and deeds, abide by party discipline, and play a vanguard and exemplary role in their work.
July 3
2018 , introduced the preliminary idea of 2019 , and asked all party members to pool their wisdom in strengthening the party's political suggestions. (Sheng Da Xue Jing Wang Qinghong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page